Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Apr;175(8):1146-1156.
doi: 10.1111/bph.13825. Epub 2017 May 24.

Protein S-sulfhydration by hydrogen sulfide in cardiovascular system

Affiliations
Review

Protein S-sulfhydration by hydrogen sulfide in cardiovascular system

Guoliang Meng et al. Br J Pharmacol. 2018 Apr.

Abstract

Hydrogen sulfide (H2 S), independently of any specific transporters, has a number of biological effects on the cardiovascular system. However, until now, the detailed mechanism of H2 S was not clear. Recently, a novel post-translational modification induced by H2 S, named S-sulfhydration, has been proposed. S-sulfhydration is the chemical modification of specific cysteine residues of target proteins by H2 S. There are several methods for detecting S-sulfhydration, such as the modified biotin switch assay, maleimide assay with fluorescent thiol modifying regents, tag-switch method and mass spectrometry. H2 S induces S-sulfhydration on enzymes or receptors (such as p66Shc, phospholamban, protein tyrosine phosphatase 1B, mitogen-activated extracellular signal-regulated kinase 1 and ATP synthase subunit α), transcription factors (such as specific protein-1, kelch-like ECH-associating protein 1, NF-κB and interferon regulatory factor-1), and ion channels (such as voltage-activated Ca2+ channels, transient receptor potential channels and ATP-sensitive K+ channels) in the cardiovascular system. Although significant progress has been achieved in delineating the role of protein S-sulfhydration by H2 S in the cardiovascular system, more proteins with detailed cysteine sites of S-sulfhydration as well as physiological function need to be investigated in further studies. This review mainly summarizes the role and possible mechanism of S-sulfhydration in the cardiovascular system. The S-sulfhydrated proteins may be potential novel targets for therapeutic intervention and drug design in the cardiovascular system, which may accelerate the development and application of H2 S-related drugs in the future.

Linked articles: This article is part of a themed section on Spotlight on Small Molecules in Cardiovascular Diseases. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v175.8/issuetoc.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Reaction mechanisms for S‐sulfhydration formation. S‐sulfhydration can be induced by H2S on cysteine sulfenic acids (Cys‐SOH, A) or cysteine disulfides (−S‐S, B), or by polysulfides on cysteine thiols (Cys‐SH, C). H2S induces S‐sulfhydration on cysteine thiols in oxidation conditions (D‐E).
Figure 2
Figure 2
Schematic illustration of possible roles of S‐sulfhydration by H2S in the cardiovascular system. H2S induces S‐sulfhydration on p66Shc to inhibit oxidative stress. S‐sulfhydration on phospholamban (PLN) promotes myocardial relaxation. S‐sulfhydration on protein tyrosine phosphatase 1B (PTP1B) restores endoplasmic reticulum stress homeostatis. H2S also S‐sulfhydrates MEK1 to repair DNA damage. ATP5A1 and transient receptor potential V4 (TRPV4) S‐sulfhydration improves ATP production and vasodilatation respectively. H2S also S‐sulfhydrates SP‐1, Keap1, NF‐κB and IRF‐1 to regulate target gene transcription, which is vital for the regulation of endothelial phenotypes, myocardial hypertrophy, oxidative stress, mitochondrial biogenesis, apoptosis and inflammation.

Similar articles

Cited by

References

    1. Akaike T, Fujii S, Sawa T, Ihara H (2010). Cell signaling mediated by nitrated cyclic guanine nucleotide. Nitric Oxide 23: 166–174. - PubMed
    1. Alexander SPH, Kelly E, Marrion N, Peters JA, Benson HE, Faccenda E et al. (2015a). The Concise Guide to PHARMACOLOGY 2015/16: Overview. Br J Pharmacol 172: 5729–5143. - PMC - PubMed
    1. Alexander SPH, Catterall WA, Kelly E, Marrion N, Peters JA, Benson HE et al. (2015b). The Concise Guide to PHARMACOLOGY 2015/16: Voltage‐gated ion channels. Br J Pharmacol 172: 5904–5941. - PMC - PubMed
    1. Alexander SPH, Cidlowski JA, Kelly E, Marrion N, Peters JA, Benson HE et al. (2015c). The Concise Guide to PHARMACOLOGY 2015/16: Nuclear hormone receptors. Br J Pharmacol 172: 5956–5978. - PMC - PubMed
    1. Alexander SPH, Fabbro D, Kelly E, Marrion N, Peters JA, Benson HE et al. (2015d). The concise guide to PHARMACOLOGY 2015/16: Catalytic receptors. Br J Pharmacol 172: 5979–6023. - PMC - PubMed

Publication types